BenevolentAI (OTC:BAIVF), a leader in AI-driven drug discovery, will participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit on 26-27 June 2024 in New York.
Dr Joerg Moeller, CEO, will join a panel discussion on Value Creation with AI for Drug Discovery at 09:55 EDT on 27 June.
The panel will be moderated by Vikram Purohit, executive director and equity analyst at Morgan Stanley (NYSE:MS). Dr Moeller and the leadership team will be available for meetings during the conference and adjacent to the programme.